Evidence map›Paper›PMID 32980498›Full record

Trial reportInternational journal of radiation oncology, biology, physics2021

Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study.

Jeremiah W Sanders, Aradhana M Venkatesan, Chad A Levitt, Tharakeswara Bathala, Rajat J Kudchadker, Chad Tang, Teresa L Bruno, Christine Starks, Edwin Santiago, Michelle Wells and 3 more

Erratum issuedOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in International journal of radiation oncology, biology, physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jeremiah W SandersDepartment of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas; Medical Physics Graduate Program, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas. Electronic address: jsanders1@mdanderson.org.
Aradhana M VenkatesanDepartment of Radiation Oncology, Piedmont Hospital, Atlanta, Georgia.
Chad A LevittDepartment of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Tharakeswara BathalaDepartment of Radiation Oncology, Piedmont Hospital, Atlanta, Georgia.
Rajat J KudchadkerDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Chad TangDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Teresa L BrunoDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Christine StarksDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Edwin SantiagoDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Michelle WellsDepartment of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Carl P WeaverDepartment of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Jingfei MaDepartment of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas; Medical Physics Graduate Program, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas.
Steven J FrankDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
The University of Texas MD Anderson Cancer Center · USPiedmont Atlanta Hospital · USThe University of Texas Health Science Center at Houston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

purposeTo investigate fully balanced steady-state free precession (bSSFP) with optimized acquisition protocols for magnetic resonance imaging (MRI)-based postimplant quality assessment of low-dose-rate (LDR) prostate brachytherapy without an endorectal coil (ERC). METHODS AND MATERIALS: Seventeen patients at a major academic cancer center who underwent MRI-assisted radiosurgery (MARS) LDR prostate cancer brachytherapy were imaged with moderate, high, or very high spatial resolution fully bSSFP MRIs without using an ERC. Between 1 and 3 signal averages (NEX) were acquired with acceleration factors (R) between 1 and 2, with the goal of keeping scan times between 4 and 6 minutes. Acquisitions with R >1 were reconstructed with parallel imaging and compressed sensing (PICS) algorithms. Radioactive seeds were identified by 3 medical dosimetrists. Additionally, some of the MRI techniques were implemented and tested at a community hospital; 3 patients underwent MARS LDR prostate brachytherapy and were imaged without an ERC.

resultsIncreasing the in-plane spatial resolution mitigated partial volume artifacts and improved overall seed and seed marker visualization at the expense of reduced signal-to-noise ratio (SNR). The reduced SNR as a result of imaging at higher spatial resolution and without an ERC was partially compensated for by the multi-NEX acquisitions enabled by PICS. Resultant image quality was superior to the current clinical standard. All 3 dosimetrists achieved near-perfect precision and recall for seed identification in the 17 patients. The 3 postimplant MRIs acquired at the community hospital were sufficient to identify 208 out of 211 seeds implanted without reference to computed tomography (CT).

conclusionsAcquiring postimplant prostate brachytherapy MRI without an ERC has several advantages including better patient tolerance, lower costs, higher clinical throughput, and widespread access to precision LDR prostate brachytherapy. This prospective study confirms that the use of an ERC can be circumvented with fully bSSFP and advanced MRI scan techniques in a major academic cancer center and community hospital, potentially enabling postimplant assessment of MARS LDR prostate brachytherapy without CT.

Indexed as

Magnetic Resonance ImagingRectumBrachytherapyHumansMaleProspective StudiesProstatic NeoplasmsRadiosurgeryRadiotherapy DosageRadiotherapy, Image-GuidedSignal-To-Noise Ratio

Identifiers

PMID32980498
PMCPMC7855300
OpenAlexW3088689119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.